THE INFLUENCE OF ANTI-ADALIMUMAB ANTIBODIES ON ADALIMUMAB THROUGH LEVELS, TNF-α LEVELS AND CLINICAL OUTCOME

被引：0
|
作者：
Bodini, G. [1 ]
Savarino, V. [1 ]
Dulbecco, P. [1 ]
Baldissarro, I. [1 ]
Savarino, E. [2 ]
机构：
[1] IRCCS San Martino, Genoa, Italy
[2] Azienda Opsedaliera, Padua, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.09.5
引用
收藏
页码：E94 / E95
页数：2
相关论文
共 50 条
  • [1] The influence of anti-adalimumab antibodies on adalimumab through levels, TNF-α levels and clinical outcome
    Bodini, G.
    Giannini, E.
    Pellegatta, G.
    Demarzo, G.
    Marabotto, E.
    Furnari, M.
    Baldissarro, I.
    Savarino, V.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 88 - 88
  • [2] The influence of anti-adalimumab antibodies on adalimumab trough levels, TNF-α levels and clinical outcome
    Bodini, G.
    Savarino, V.
    Dulbecco, P.
    Baldissarro, I.
    Savarino, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S42 - S42
  • [3] Correlation Between Adalimumab Trough Serum Concentration, Anti-Adalimumab Antibodies and TNF-α Levels With Clinical Outcome in Patients Affected by Crohn's Disease
    Bodini, Giorgia
    Savarino, Vincenzo
    Dulbecco, Pietro
    Assandri, Lorenzo
    Bruzzone, Linda
    Mazza, Fabrizio
    Fazio, Valentina
    Giambruno, Elisa
    Gemignani, Lorenzo
    Savarino, Edoardo
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S780 - S780
  • [4] Detection of Adalimumab and Anti-Adalimumab Levels by ELISA: Clinical Considerations
    Marinari, Barbara
    Botti, Elisabetta
    Bavetta, Mauro
    Spallone, Giulia
    Zangrilli, Arianna
    Talamonti, Marina
    Richetta, Antonio
    Chimenti, Sergio
    Costanzo, Antonio
    [J]. DRUG DEVELOPMENT RESEARCH, 2014, 75 : S11 - S14
  • [5] Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
    van Kuijk, A. W. R.
    de Groot, M.
    Stapel, S. O.
    Dijkmans, B. A. C.
    Wolbink, G. J.
    Tak, P. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 624 - U187
  • [6] Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Pellegatta, Gaia
    De Maria, Costanza
    Baldissarro, Isabella
    Savarino, Edoardo
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1081 - 1086
  • [7] ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN'S DISEASE PATIENTS
    Pellegatta, G.
    Lo Pumo, S.
    Bodini, G.
    Baldissarro, I.
    Giannini, E. G. B.
    Savarino, V.
    Jain, A.
    Savarino, E.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E135 - E135
  • [8] NO PREDICTIVE VALUE OF ADALIMUMAB SERUM LEVELS AND ANTI-ADALIMUMAB ANTIBODIES AT TIME OF ADALIMUMAB FAILURE FOR PREDICTION OF RESPONSE TO THE NEXT BDMARD
    Den Broeder, N.
    Ulijn, E.
    Wientjes, M.
    Van Herwaarden, N.
    Meek, I.
    Tweehuysen, L.
    Van der Maas, A.
    Van den Bemt, B.
    Den Broeder, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1388 - 1389
  • [9] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
    Bartelds, Geertje M.
    Wijbrandts, Carla A.
    Nurmohamed, Michael T.
    Stapel, Steven
    Lems, Willem F.
    Aarden, Lucien
    Dijkmans, Ben A. C.
    Tak, Paul Peter
    Wolbink, Gerrit Jan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) : 921 - 926
  • [10] Adalimumab/naproxenLack of efficacy and anti-adalimumab antibodies: case report
    [J]. Reactions Weekly, 2021, 1866 (1) : 17 - 17
12345